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Abstract 
Background: J point elevation is common in athletes, nevertheless the 
influence of structural changes associated with the athlete’s heart and its 
prognostic impact are still debated. Our aim was to investigate the prevalence 
of J point elevation, the associated clinical, electrocardiographic and 
echocardiographic characteristics and its impact on long-term outcome in elite 
soccer players. 
Methods and Results: clinical, electrocardiographic and cardiopulmonary 
exercise test data from 332 male professional soccer players were 
retrospectively analyzed. For 235 (70.7%) athletes echocardiographic data were 
also available. J point elevation was defined as an elevation ≥ 1 mm in at least 
two contiguous leads. Long-term follow-up data were obtained for all athletes, 
while univariate and multivariable analyses were performed to assess the 
associated characteristics. 
Overall, 118 (35.6%) athletes showed a J point elevation ≥1 mm. At 
multivariable analysis a significant direct association of interventricular septum 
thickness (OR 1,224 95%CI 1,014-1,478; p=0,036) and  Sokolow Lyon index (OR 
1,031 95% CI 1,002-1,060, p=0,033) and an inverse association of baseline 
heart rate (OR 0.985, CI 95% 0.945-0.993, p=0.011) with J point elevation were 
observed. 
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Over a long-term follow-up (median 13,3 years; interquartile range 10,1-17,03 
years) no differences in survival were observed between groups (0% vs. 0,01%, 
p=0.294). 
Conclusions:  The correlation between J point elevation and interventricular 
septum thickness suggests a possible mechanistic role of exercise induced left 
ventricular hypertrophy as the basis for J point elevation. After a long-term 
follow-up, no significant differences in survival were observed between 
athletes with and without J point elevation. 
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Introduction 
For more than 70 years since its original description1, the electrocardiographic 
pattern defined as “early repolarization” (ER) or “juvenile ST variant”, 
characterized by an elevated take off of the S-T segment at the J junction of the 
QRS complex and an upward concavity of the S-T segment has been considered 
as a normal common variant. 
In the general population, its prevalence ranges between 5% and 13% while in 
athletes rises from 20 to 90%2-4.  
From the second half of the ’90s, a growing number of case reports, case 
series, observational and prospective studies reported that the presence of 
various electrocardiographic patterns attributed to ER but defined only by the 
presence of a J point elevation with or without ST segment displacement, may 
constitute a potential marker of increased risk of sudden death in otherwise 
normal subjects, casting a dark shadow on this ECG peculiarity5-8. Doubts about 
its real prognostic impact were emphasized even more during the pre-
participation screening of competitive athletes, prompting the need for a broad 
cardiological evaluation, often including also an arrhythmological consultation 
with subsequent increase in costs.  
The classical ER morphology characterized by the combination of J point 
elevation and elevated ST segment with an upward concavity has not been 
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recognized as a marker of risk in the general population2,3,7,8. For this reason, 
the classical ER pattern found in athletes, by inference from the general 
population2 and from short-term follow up studies9, is considered a benign 
phenomenon. In contrast, evidence of an increased risk for sudden death exists 
for ER patterns characterized by the presence of a J point elevation associated 
with a horizontal/descending ST segment. Two main questions remain 
unanswered: 1) is J point elevation observed in competitive athletes somehow 
linked to structural changes associated with the athlete’s heart or is it a mere 
electrophysiological phenomenon? 2) does J point elevation really imply an 
ominous prognosis in competitive athletes? 
Recent studies have investigated the prevalence of J point elevation and the 
clinical, electrocardiographic and structural left ventricular characteristics 
associated with this ECG finding in various types of competitive athletes (from 
intercollegiate to Olympic), reporting only short-term  follow-up data2,9. 
The aim of this work is to investigate the prevalence of J point elevation, its 
clinical, electrocardiographic and echocardiographic characteristics in a 
population of elite soccer players, to search for correlations with the classical 
structural and electrocardiographic features of the athlete’s heart and to 
describe the outcome at long-term follow-up. 
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Methods: 
Study design and population 
Overall, 338 male professional elite athletes, members of soccer clubs 
participating in the Italian national soccer championships, who underwent  the 
first pre-participation screening between June 1980 and April 2008 at the Turin 
Institute of Sport Medicine were screened and retrospectively evaluated. Six 
subjects with negative T waves with a voltage >0.2 mV in more than 2 
contiguous leads (one subsequently diagnosed with a mild form of 
hypertrophic cardiomyopathy) were excluded. The final cohort consisted of 332 
subjects with an age between 15 and 37 years. The pre-participation screening 
consisted in the collection of a detailed clinical, physiological, familial, 
pharmacological and training history and in a complete physical examination. 
All subjects underwent a 12 lead ECG recording and a symptom-limited 
cardiopulmonary exercise test (Bruce protocol) with expired gas analysis. In 
subjects evaluated from 1989 to 1995, echocardiography was performed at 
discretion of the evaluating physician, afterwards all athletes underwent 
echocardiography.  
ECG analysis 
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All electrocardiograms were retrospectively analyzed by two independent 
reviewers who were blinded to all subjects characteristics. In ambiguous cases 
final adjudication was achieved by consensus with a third reviewer. 
All measurements were obtained with the use of 4x magnification lens. For all 
voltage measurements, the isoelectric line was considered to be the PR 
segment. 
Heart rate, P wave duration, PR interval, QRS duration, QT interval were 
measured in lead II. In case of a J point elevation evident in lead II, QRS 
duration was measured in lead I. Correction of the QT interval was obtained 
using the Bazett’s formula (QTc=QT/√RR). The presence of left atrial 
enlargement, first and second degree type I atrioventricular block, left anterior 
fascicular block, left posterior fascicular block, complete/incomplete, right and 
left bundle block was defined according to the AHA/ACCF/HRS 
recommendations for ECG interpretation10-12. QRS amplitude was recorded as a 
continuous variable using both the Sokolow-Lyon (S in V1 + R in V5 or V6 
whichever greater) and the Cornell voltage index (R in aVL + S in V3). Voltage 
criteria for left ventricular hypertrophy were defined by the presence of at 
least one between the Sokolow-Lyon ≥ 35 mm and the Cornell voltage index  ≥ 
28 mm. 
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The ECG was deemed consistent with a J point elevation if an elevation ≥ 1 mm 
of the J point was evident in at least two contiguous leads. The height of J point 
elevation was measured in the lead showing the greatest elevation. The 
presence of J point elevation was categorized in each of the twelve leads 
separately and by territory (anterior [V1 to V3], inferior [II,III,aVF], lateral [V4 to 
V6, I and aVL]). In line with the original definition of ER1,14,16,  J point elevation 
in the anterior leads (from V1 to V3) was not excluded. 
In subjects with J point elevation, the QRS-ST transition was classified into 3 
groups according to its morphology in each lead. ER without J wave was 
defined by the combined presence of J point and ST segment elevation in the 
absence of any J wave. As previously reported2,3, a notched J wave was defined 
by the presence of a sharp and well-defined hump immediately after the R-
wave, while a slurred J wave was identified when the QRS-ST transition was 
characterized  by a change in the slope of the terminal portion of the R wave 
(figure 1). To estimate the entity of J point elevation in this subgroup of 
subjects the J point elevation at the intersection between the tangents of the 
descending limb of the QRS complex and the J wave was measured. 
The morphology of the ST segment was classified in concave/rapidly ascending 
(elevation of the ST segment >1 mm within 100 ms after the J point or after the 
change in slope of the terminal portion of the QRS complex) and 
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horizontal/descending (ST-segment elevation ≤1 mm within 100 ms after the J 
point or after the change in slope of the terminal portion of the QRS complex)2. 
Echocardiography 
A complete echocardiographic assessment, performed during their first 
evaluation by a single experienced cardiologist, was available for 235 athletes. 
Echocardiography was performed in order to obtain cardiac chambers 
measurements and to exclude the presence of structural heart disease. 
Measurements of left atrial anteroposterior diameter, left ventricular (LV) wall 
thickness, LV systolic and diastolic diameters, volumes and ejection fraction 
were obtained in compliance with contemporary guidelines13.  
Follow up 
For 269 (81.0%) athletes repeated clinical and electrocardiographic evaluations 
were available. The occurrence of events during follow-up was ascertained for 
all athletes looking through Turin’s Institute of Sport Medicine archive, the 
soccer club’s databases and the National soccer player Association online 
database. Follow-up started from the date of the first preparticipation 
screening and lasted until October 2012. 
Statistical analysis 
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Descriptive analysis was performed using mean ± standard deviation for 
continuous variables and counts and percentages for categorical variables. 
Comparisons between groups were performed with the Student’s t-Test, one 
way ANOVA and Yates corrected or uncorrected Chi-squared method when 
appropriate. All probability values were considered to be significant at a value ≤ 
0.05. Only data of athletes who underwent echocardiographic examination 
were used for univariate and multivariable logistic regression analysis with a 
stepwise approach to identify characteristics associated with the presence of J 
point elevation. Using the entire population follow-up data, Kaplan Meier 
survival curves were plotted, stratifying by the presence/absence of J point 
elevation. All the analyses were performed with SPSS software (SPSS, Chicago, 
IL).  
Results 
Clinical characteristics of athletes are shown in table 1.  Mean age at the time 
of ECG recording was 23.6±5.3 years; black athletes represented the 8.1% of 
the population. Average maximal oxygen consumption and maximal work load 
achieved during symptom-limited cardiopulmonary exercise test were 
respectively 53.5±11.0 ml/(kg min) and 237.7±41.4 Watts (W), consistent with 
a top level physical training for soccer players.  
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Two hundred and fourteen (64.4%) athletes showed an isoelectric J point (ISO J 
group) while in 118 (35.6%)  a J point elevation ≥1 mm (ELE J group) at basal 
ECG was present. Excluding the anterior leads (from  V1 to V3) any other type 
of J point elevation was evident in 85 (25.6%) subjects. 
The presence of J point elevation was more frequent in black than in white 
athletes (62.9% vs. 33.1%; RR 1.901, 95% CI 1.366-2.647, p=0.003). No 
significant differences in terms of age, weight, height, body surface area were 
evident between athletes with and without J point elevation. Exercise capacity 
and maximal aerobic capacity did not significantly differ between athletes with 
and without J point elevation.  
Electrocardiographic characteristics 
Basal ECG parameters are shown in table 2. J point elevation was more 
frequently observed in subjects with slower heart rate (ISO J group: 59.8±13.6 
bpm vs. ELE J group: 54.6±10.0 bpm, p <0,001) and increased voltage of the 
precordial leads evaluated with Sokolow Lyon index (ISO J group 30.3±9.1 vs. 
ELE J group 34.2±11.3, p<0,001; RR for positive Sokolow index 1.392 95% CI 
1.045-1.853, p=0.034). Moreover, subject with J point elevation showed  
shorter QRS duration (ISO J group 85.1±9.7 ms vs. ELE J group: 82.5±9.4 ms, 
p=0.019) and shorter corrected QT interval (ISO J group 391.8±30.3 ms vs. ELE J 
group 384.4±29.1 ms, p=0.032). 
12 
 
In ELE J group, average J point elevation was 1.9±0.9 mm (range between 1 and 
6 mm) and J point elevations greater than 3 mm were rarely found (5.1% of 
subjects, Fig.2, left panel). 
Mean number of leads showing a J point elevation (including V1-V3) was 
3.4±1.4 (range between 2 and 8, Fig. 2, right panel). 
QRS-ST transition morphology 
Distribution of different QRS-ST transition morphologies in ELE J group is shown 
in table 3.  
Subjects with notched, slurred J waves and ER without J wave respectively 
showed a progressive lengthening of the QRS complex duration (notched J 
waves 78.8±8.8 ms; slurred J waves 81.3±8.3; ER without J wave: 85.7±9.9; 
p=0.005).   
J point elevation distribution 
Considering only athletes with a single morphology of the QRS-ST transition, 40 
(33.8% of the ELE J group) subjects showed a J point elevation in the lateral (V4 
to V6) leads, 26 (22.0% of the ELE J group) in the anterior (V1 to V3) leads, 17 
(14.4% of the ELE J group) in the inferior (II, III and aVF) leads, 7 (5.9% of the 
ELE J group) both in the anterior and lateral leads and only 5 (1.5% of the ELE J 
group) in the inferior and lateral leads. 
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Considering QRS-ST transition in any single lead in the ELE J group (figure 3) ER 
without J wave was more common in the anterior leads, while the presence of 
a notched or slurred J waves was more frequently observed in lateral and 
inferior leads, respectively. 
ST segment morphology 
Ascending ST segment was present in 95 (80.5%) athletes while 
horizontal/descending in 23 (19.5%) in the ELE J group. In subjects with 
horizontal/descending ST segment 13 (3.9%) showed slurred  J waves, 4 (1.2%) 
notched J waves while 6 (1.8%) both notched and slurred J waves. Considering 
the spatial distribution of J point elevation and J waves associated with a 
horizontal/descending ST segment, 13 athletes showed this pattern in the 
inferior leads (9 with a notched and 4 with a slurred J wave), 2 in the lateral 
leads (all notched) and 6 both in inferior and lateral leads (2 with notched J 
waves and 4 with slurred J wave in the inferior and notched J wave in the 
lateral leads). The combined presence of J point elevation, slurred J wave and 
horizontal/descending ST segment, recognized in the general population as a 
possible marker of arrhythmic risk, was rare, manifest only in 4 (1.2%) athletes. 
Echocardiography 
Complete echocardiographic data were available for 147 athletes of the ISO J 
group and for 88 of the ELE J group (Table 3). No significant differences were 
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observed between groups in terms of LV diameters, ejection fraction or left 
atrial anteroposterior diameter. Interventricular septum resulted significantly 
thicker in subjects with, compared to those without J point elevation (ISO J 
group 10.2±1.4 mm vs.  ELE J group 10.8 ± 1.6 mm; p =0.002), while LV 
posterior wall thickness was almost significantly thicker in the former group 
compared to the latter (ISO J group 9.3±1.1 mm vs. ELE J group 9.6 ± 1.3 mm; 
p=0.06). 
Univariate analysis revealed that black race, lower heart rate, Sokolow Lyon 
index and interventricular septum thickness were significantly associated with 
the presence of J point elevation. After adjusting for all these significant 
variables, lower heart rate (OR 0.968 95% CI 0.945- 0.993; p=0.011), increased 
interventricular septum thickness (OR 1.224 95%CI 1.014-1.478; p=0.036) and 
Sokolow Lyon index (OR 1.031 95% CI 1.002-1.060, p=0.033), but not black race 
(OR 0.424 95% CI 0.147-1.224; p=0.113), were significantly associated with J 
point elevation.  
Follow up 
Follow up data were available for the entire cohort of athletes. During follow- 
up (median 13,3 years; interquartile range 10,1-17,03 years) 2 deaths, due to 
non-cardiovascular reasons, were observed. One subject died at the age of 23  
for acute leukemia. Another subject died in a road accident at the age of 28. In 
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none of the ECGs available for these two athletes a J point elevation was ever 
observed. Accordingly, no differences in the overall survival between subjects 
with and those without J point elevation were observed (p=0.294, fig.4). 
 
Discussion 
This retrospective analysis of a cohort of elite soccer players provided the 
opportunity to examine the clinical significance of J point elevation in the 
competitive sport setting, a field in which this ECG sign has been less 
investigated so far. The main findings of our study are: 1) the significant 
association between J point elevation and markers of left ventricular structural 
remodeling (e.g. increased interventricular septum thickness and Sokolow-Lyon 
index) as well as with lower resting heart rate; 2) after a long-term follow-up, 
no significant differences in survival were observed between athletes with and 
without J point elevation. 
Previous studies recognized, in the general population or in non-professional 
athletes, the association between the presence of J point elevation and young 
age, male gender, black race, slower heart rate, increased voltage of the QRS 
complexes and enhanced aerobic fitness 9,14-17.  A recent work by Noseworthy 
et al. reported that, in a subgroup of football and rowing athletes, J point 
elevation on surface ECG was not significantly associated with any parameter 
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of structural remodeling typical of the athlete’s heart, supporting the 
hypothesis that the evidence of J point elevation is a mere electrophysiological 
phenomenon and that it is not related to any form of exercise-induced left 
ventricular remodeling9. 
Our work has confirmed the association, already found in previous studies, 
between J point elevation, slower heart rate and increased QRS voltages in the 
precordial leads. Interestingly, a significant  association between J point 
elevation and a thicker intraventricular septum was also observed both at 
univariate  and  multivariable analysis. The homogeneous sample of elite 
athletes under study, practicing the same type of high-intensity training, may 
have favored this observation. Posterior wall thickness was not considered as a 
covariate in multivariable analysis because not significant at univariate analysis.  
The presence of a mild form of left ventricular hypertrophy is a cornerstone of 
the “athlete’s heart” and our findings suggest exercise induced left ventricular 
remodeling as the potential structural basis for J point elevation at surface ECG.  
Marked echocardiographic LV hypertrophy has been demonstrated in athletes 
of black ethnicity. However, only interventricular septum thickness but not 
black race was retained in our multivariable model, supporting the hypothesis 
of a mechanistic link between cardiac remodeling and J point elevation. A 
possible explanatory mechanism, based on animal studies18 and sporadic case 
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reports in human, linking mild LV hypertrophy and QRS shortening was 
proposed by Boineau. According to this hypothesis an increased LV endocardial 
trabeculation and a greater endocardial invagination depth, may be associated 
with a deeper localization (into the mid myocardium) of the Purkinje fibers and 
may provide the anatomical basis for a faster activation of the thickened left 
ventricular walls19. The same mechanism was also recently proposed to explain 
the high prevalence of J point elevation in a population of patients with left 
ventricular non compaction cardiomyopathy20.  An increased left ventricular 
trabeculation is associated with physical training. In fact, a recent MRI study 
comparing soccer players of European versus African descent reported a 
greater degree of myocardial trabeculation in the latter.  According to in vitro 
studies21, small gradients in ventricular repolarization (i.e. small differences in 
action potential duration in contiguous myocardial regions) exist in the normal 
left ventricle and are responsible for the J-point elevation; as this dispersion of 
repolarization increases in magnitude, increasingly taller J waves become 
manifest on the surface ECG.  The presence of a mild form of ventricular 
trabeculation associated with hypertrophy may allow for a more rapid 
ventricular activation (evident as a shorter QRS complex) revealing the 
presence of J point elevation and J waves. QRS duration and coupling time 
between QRS complexes and J waves may influence both J point appearance 
and the morphology of the transition between QRS and ST segment. As a 
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matter of fact, in our population, the duration of QRS complex not only differed 
between subjects with and without J point elevation, but a trend for a 
progressively longer QRS complex was observed in subjects with notched, 
slurred J waves and early repolarization without J wave respectively. 
Interestingly and apparently in contrast with previous studies conducted in 
non-professional athletes, in our population of elite athletes the presence of J 
point elevation was not associated with an increased aerobic fitness or 
maximal work load. This finding may be due to a ceiling effect in the incidence 
of J point elevation in highly trained athletes.   
In our work the presence of a J point elevation was evident in more than 1 out 
of 3 professional top level soccer players: in this population, after a long-term 
follow-up no significant differences in survival were observed between athletes 
with and without J point elevation. This finding, should reassure Sport Medicine 
physicians performing pre-participation screening of athletes with 
unremarkable clinical history, avoiding unnecessary, time consuming and 
expensive subsequent evaluations. 
Some limitations of our study should be acknowledged. The estimated risk of 
sudden cardiac death of subjects with J point elevation is very low, 
approximating 11 in 100000 over 10 years in the general population8. Even if 
the risk of sudden cardiac death is more than doubled in active compared with 
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sedentary subjects, the population included in the present study is too small to 
draw definite conclusions on the real prognostic impact of J point elevation in 
athletes. Nevertheless, to the best of our knowledge, to date this is the largest, 
long-term follow-up study investigating clinical features associated with J point 
elevation in elite athletes.     
In conclusion, in our series of elite soccer players enrolled over 3 decades, 
more than one out of three showed a J point elevation confirming its high 
prevalence amongst physically active subjects. The correlation between J point 
elevation and increased interventricular septum thickness suggests a possible 
mechanistic role of exercise induced left ventricular hypertrophy in the genesis 
of early repolarization.  
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Table 1. Clinical parameters 
 Total 
Population 
N=332 
Isoelectric
J point 
N=214 
Any J point 
elevation 
N=118 
p-value
Mean age at first ECG, years 23.6±5.3 23.6±5.2 23.5±5.5 0.869
Anthropometrics  
Weight, kg 75.7±7.2 75.6±7.2 75.8±7.2 0.808
Height, cm 180.0±5.9 180.2±5.7 179.6±6.1 0.371
BSA, m2 1.9±0.1 1.9±0.1 1.9±0.1 1
 
Race, n(%) 
 
White
Black
305(91.9)
27(8.1) 
204(95.3)
10(4.7) 
101(85.6)
 17(14.4) 
0.003
 
Exercise Capacity 
 
VO2 max,(ml/(kg min)) 53.5±11.0 53.3±12.3 54.0±8.4 0.582
Maximal work load, W 237.7±41.4 236.8±40.5 239.2±43.1 0.614
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Table 2. Basal ECG parameters 
ECG parameters Total
Population
N=332 
Isoelectric
J point 
N=214 
Any J point 
elevation 
N=118 
p-value
Rhythm  
Sinus rhythm, n(%) 324(95,9) 208(97,2) 110(93,2) 
Atrial rhythm, n(%) 13(3.8) 5(2.3) 8(6.8) 0.150*
Junctional rhythm, n(%) 1(0.3) 1(0.5) 0(0) 
Heart rate, bpm 57.9±12.7 59.8±13.6 54.6±10.0 <0.001
P wave duration, ms 87.3±15.4 87.2±15.3 86.9±15.6 0.865
ECG criteria for left atrial 
enlargement, n(%) 
1(0.3) 0(0) 1(0.8) 
PR interval, ms 163.8±27.2 161.5±24.9 166.3±29.0 0.114
AV conduction*  
Normal, n(%) 320(94.7) 206(96.3) 110(93.2) 0.236† 
I degree AV block, n(%) 16(4.7) 7(3.3) 7(6.0) 
II degree type 1 AV block, n(%) 1(0,3) 0(0) 1(0.8) 
QRS duration, ms 84.3±9.7 85.1±9.7 82.5±9.4 0.019
QRS axis, ° 65.1±24.1 64.8 ±23.9 66.2±23.5 0.608
Not determinable 4(1.2) 0(0) 1(0.8) 
Intraventricular conduction 
defect, n (%) 
15(4.5) 9(4.2) 5(4.2) 0.786‡ 
Anterior fascicular block, n(%) 2(0.6) 0(0) 1(0.9) 
Posterior fascicular block, n(%) 1(0.3) 0(0) 1(0.9) 
Complete RBBB, n(%) 1(0.35) 1(0.5) 0(0) 
Incomplete RBBB, n(%) 11(3.3) 8(3.7) 3(2.5) 
Complete LBBB, n(%) 0(0) 0(0) 0(0) 
QT interval, ms 401.0±34.8 397.3±35.9 406.1±31.5 0.026
Corrected QT interval, ms 389.3±30.0 391.8±30.3 384.4±29.1 0.032
Sokolow Lyon index, mm 31.8±10.2 30.3±9.1 34.2±11.3 <0.001
Positive Cornell Voltage index, 
n(%) 
22(6.5) 16(7.5) 4(3.4) 0.209
Negative T waves, n(%) 6 (1.8) / / 
* sinus rhythm (SR) vs other than SR
† Normal AV conduction vs. first and second degree type 1 AV block 
‡ Normal vs. intraventricular conduction defect 
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Table 3. Echocardiographic parameters. 
Characteristics Isoelectric
J point  
N=147 
Any J point 
elevationN=88
p-value 
Interventricular septum 
thickness, mm
10.2±1.4 10.8±1.6 0.002 
Posterior wall thickness, mm 9.3±1.1 9.6±1.3 0.06 
LVEDD, mm 54.8±4.1 54.4±4.0 0.466 
LVESD, mm 35.3±3.4 34.8±3.6 0.287 
EF, % 64.2±3.2 64.3±4.5 0.843 
Left atrial AP diameter, mm 35.2±3.9 35.4±4.4 0.717 
Left ventricular mass/BSA, g/m2 106.8±19.8 111.1±20.6 0.113 
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Table 4. Morphologies of the QRS-ST transition. 
 Isoelectric
J point  
N(%) 
Single  95
ER without J wave 53(44.9%)
Notched J waves 34(28.8%)
Slurred J waves 8(6.8%)
Combined  23
Notched + Slurred J waves 7(5.9%)
Notched + ER without J wave 12(10.1%)
Slurred + ER without J wave 1(0.8%)
Notched+ Slurred + ER without J wave 3(2.5%)
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Figure 1: Morphologies of the QRS-ST transitions: A) early repolarization 
without J wave; B) notched J wave with ascending ST segment; C) notched J 
wave with horizontal/descending ST segment; D) slurred J wave with ascending 
ST segment; E) slurred J wave with horizontal/descending ST segment. 
 
 
31
Figure 2. Left panel: distribution of the amplitudes of J point elevation. Right 
panel: distribution of the number of leads with a J point elevation ≥1 mm. 
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Figure 3. Distribution of the different QRS-ST transition morphologies in 
different leads. 
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Figure 4. Kaplan Meier survival curves of athletes with and without J point 
elevation. 
 
P=0,294 
